Eli Lilly Unveils Breakthrough Cancer Treatments

Eli Lilly is making waves at the 2026 American Society of Clinical Oncology Annual Meeting with a slew of presentations showcasing their latest cancer treatments. They've got results from two major studies: one on Retevmo for lung cancer and another on Verzenio for liposarcoma. Plus, there's new data on an experimental therapy for multiple myeloma from Kelonia Therapeutics, a company Lilly plans to acquire. What does it mean for you? If you or someone you know is affected by these types of cancer, these developments could mean more treatment options in the future. For everyone else, it's a promising sign that cancer research is advancing and bringing new hope to patients.